Literature DB >> 31024806

Autophagy: a new mechanism for regulating VEGF and PEDF expression in retinal pigment epithelium cells.

Rong Li1, Jun-Hui Du2, Guo-Min Yao1, Yang Yao3, Jin Zhang4.   

Abstract

AIM: To investigate the regulation of vascular endothelial growth factors (VEGF) and pigment epithelium-derived factor (PEDF) expression by autophagy in retinal pigment epithelium (RPE) cells on exposure to hypoxia.
METHODS: ARPE-19, an RPE cell line, was treated as following: the control group was kept in a normoxic incubator; the hypoxia group was incubated in a hypoxic incubator with 1% O2/5% CO2/94% N2 for 24h; the hypoxia + 3-methyladenine (3-MA) group was pretreated with 10 mmol/L 3-MA for 1h and then in the hypoxic incubator for 24h; and the hypoxia + chloroquine (CQ) group was pretreated with 50 µmol/L CQ for 1h and then in the hypoxic incubator for 24h. The morphology and ultrastructure of the cells was observed by an inverted microscope or a transmission electronic microscope (TEM). Western blot was performed to assay the expression of autophagy-associated markers, including microtubule associated protein 1 light chain 3 B (LC3B), Beclin-1, Atg5 and p62. The concentration of VEGF and PEDF in the culture supernatant was determined by ELISA, and the ratio of VEGF/PEDF was calculated.
RESULTS: There were no obvious differences in cell morphology among different groups and autolysosomes could be observed in the cytoplasm in all groups. Compared to the control cells, the LC3B-II/I ratio and levels of Beclin-1 and Atg5 were significantly increased and p62 level was significantly decreased in the hypoxia group. With the increase of VEGF and decrease of PEDF concentration, the VEGF/PEDF ratio was significantly increased in the hypoxia group compared to the control cells. The LC3B-II/I ratio was significantly reduced by 3-MA treatment and increased by CQ treatment. The expressions of Beclin-1 and Atg5 were significantly reduced by 3-MA or CQ treatment, while expression of p62 was increased in the 3-MA or CQ treated cells. The concentration of VEGF was significantly decreased and PEDF increased, thereby the VEGF/PEDF ratio was decreased in the hypoxia + 3-MA group and hypoxia + CQ group compared with that in the hypoxia group.
CONCLUSION: Hypoxia leads to elevated autophagy in RPE cells, and expression of VEGF and PEDF might be regulated by autophagy on exposure to hypoxia to further participate in regulating the formation of retinal neovascularization.

Entities:  

Keywords:  angiogenesis; autophagy; pigment epithelium-derived factor; retinal pigment epithelium cells; vascular endothelial growth factors

Year:  2019        PMID: 31024806      PMCID: PMC6469569          DOI: 10.18240/ijo.2019.04.05

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  10 in total

1.  Chloroquine regulates the proliferation and apoptosis of palate development on mice embryo by activating P53 through blocking autophagy in vitro.

Authors:  Jing Chen; Yaxia Yao; Xiaotong Wang; Yijia Wang; Tianli Li; Juan Du
Journal:  In Vitro Cell Dev Biol Anim       Date:  2022-08-10       Impact factor: 2.723

2.  A novel sprayable thermosensitive hydrogel coupled with zinc modified metformin promotes the healing of skin wound.

Authors:  Zhengwei Liu; Wanze Tang; Jiayi Liu; Yingying Han; Qinnan Yan; Yuechao Dong; Xiaomei Liu; Dazhi Yang; Guixing Ma; Huiling Cao
Journal:  Bioact Mater       Date:  2022-07-01

3.  Phosphorylation of STAT3 and ERBB2 mediates hypoxia‑induced VEGF release in ARPE‑19 cells.

Authors:  Soohyun Hwang; Hyemin Seong; Jinhyun Ryu; Joo Yeon Jeong; Tae Seen Kang; Ki Yup Nam; Seong Wook Seo; Seong Jae Kim; Sang Soo Kang; Yong Seop Han
Journal:  Mol Med Rep       Date:  2020-07-16       Impact factor: 2.952

4.  Effects of FTMT Expression by Retinal Pigment Epithelial Cells on Features of Angiogenesis.

Authors:  Undral Buyandelger; Douglas G Walker; Daijiro Yanagisawa; Toshifumi Morimura; Ikuo Tooyama
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

5.  Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy.

Authors:  Michał Chrząszcz; Weronika Pociej-Marciak; Katarzyna Żuber-Łaskawiec; Bożena Romanowska-Dixon; Marek Sanak; Katarzyna Michalska-Małecka; Mojca Globočnik Petrovič; Izabella Karska-Basta
Journal:  Medicina (Kaunas)       Date:  2021-10-05       Impact factor: 2.430

6.  The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration.

Authors:  Magdalena Musiał-Kopiejka; Katarzyna Polanowska; Dariusz Dobrowolski; Katarzyna Krysik; Edward Wylęgała; Beniamin Oskar Grabarek; Anita Lyssek-Boroń
Journal:  Int J Environ Res Public Health       Date:  2022-02-17       Impact factor: 3.390

7.  Inhibition of PI3K/AKT/mTOR Signalling Pathway Activates Autophagy and Suppresses Peritoneal Fibrosis in the Process of Peritoneal Dialysis.

Authors:  Miao Jia; Hong Qiu; Lihua Lin; Shun Zhang; Damei Li; Donghua Jin
Journal:  Front Physiol       Date:  2022-03-04       Impact factor: 4.566

8.  PEDF-Mediated Mitophagy Triggers the Visual Cycle by Enhancing Mitochondrial Functions in a H2O2-Injured Rat Model.

Authors:  Jae Yeon Kim; Sohae Park; Hee Jung Park; Se Ho Kim; Helen Lew; Gi Jin Kim
Journal:  Cells       Date:  2021-05-06       Impact factor: 6.600

Review 9.  A Re-Appraisal of Pathogenic Mechanisms Bridging Wet and Dry Age-Related Macular Degeneration Leads to Reconsider a Role for Phytochemicals.

Authors:  Roberto Pinelli; Francesca Biagioni; Fiona Limanaqi; Miorica Bertelli; Elena Scaffidi; Maico Polzella; Carla Letizia Busceti; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2020-08-03       Impact factor: 5.923

10.  Effect of glycemic control and dyslipidemia on plasma vascular endothelial growth factor and pigment epithelium-derived factor in diabetic retinopathy patients in Northern Nigeria.

Authors:  Paulinus Jimmy Unung; Iya Eze Bassey; Maisie Henrietta Etukudo; Alphonsus Ekpe Udoh; Mahmoud B Alhassan; Uwem Okon Akpan
Journal:  Int J Health Sci (Qassim)       Date:  2020 Nov-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.